Regulation of food and dietary supplements by the U.S. Food and Drug Administration,
Marketing,
Cingulata,
Attention deficit hyperactivity disorder predominantly inattentive,
Database,
Senior,
Adolescence,
HCP,
Patient,
Food,
Pharmacovigilance,
Precision Time Protocol Industry Profile,
ADHD,
Physician,
Child,
FDA,
Partnership,
Dietary supplement,
Pharmaceutical industry,
Indegene KANSAS CITY, Kan. and PRINCETON, N.J., March 13, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, and Indegene, a digital-first, life sciences commercialization company, today announced a joint commercialization agreement to provide commercial support for Cingulate’s lead candidate CTx-1301 (dexmethylphenidate), a novel, investigational treatment being developed as a true, once-daily stimulant medication for attention deficit/hyperactivity disorder (ADHD), upon approval from the U.S. Food and Drug Administration (FDA).
Key Points:
- Cingulate recently announced the initiation of its first Phase 3 trial for CTx-1301, an adult dose-optimization efficacy and safety study to assess onset and duration, with results expected in the third quarter of 2023.
- In addition, the Company plans to initiate its pivotal Phase 3 trial, a fixed-dose, placebo-controlled study in pediatric and adolescent patients with ADHD, in mid-2023.
- “This agreement provides a clear path to commercialize CTx-1301, upon FDA approval, designed specifically to tackle the unmet needs of this $20 billion market by providing the first true, entire-active-day treatment for ADHD.
- But the clinical success of a potential treatment can only be realized with commercial excellence, making this partnership between Cingulate and Indegene a critical step for our Company,” said Shane J Schaffer, Chairman and CEO, Cingulate.
Retrieved on:
Tuesday, February 21, 2023
Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds.
Key Points:
- Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds.
- Using these, life sciences organizations can foster immersive healthcare experiences, like interactions with HCPs in a virtual medical congress, meeting for a virtual educational lecture, or facilitating interactions in a virtual patient hub.
- “Life sciences organizations are looking to reimagine healthcare interactions and be ahead of the curve.
- The company has been named a Leader in Everest Group’s Life Sciences Commercial Services Specialists PEAK Matrix® Assessment 2022.
Retrieved on:
Tuesday, January 10, 2023
With this center, Indegene is further strengthening its presence in Europe to help life sciences companies fast-track digital transformation across the commercialization value chain.
Key Points:
- With this center, Indegene is further strengthening its presence in Europe to help life sciences companies fast-track digital transformation across the commercialization value chain.
- Indegene’s local expert teams will work closely with clients in Germany and across Europe to provide consulting services and healthcare solutions.
- “Germany is a key market for life sciences companies in Europe.
- Indegene has been named a Leader in the Everest Group’s Life Sciences Commercial Services Specialists PEAK Matrix Assessment®2022.
Retrieved on:
Monday, December 19, 2022
Organizational founder,
Scalar field solution,
Executive,
Health minister,
Health,
Patient,
Growth,
Faculty,
Physician,
Senior,
Management,
Indegene PRINCETON, N.J. and BENGALURU, India, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Peter Marchesini as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.
Key Points:
- PRINCETON, N.J. and BENGALURU, India, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Peter Marchesini as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.
- At Indegene, Peter will drive strategic client engagement with a focus on the commercial segment of the life sciences value chain.
- I look forward to working with clients to fully realize their commercialization potential through our digital-first approach,” said Peter Marchesini, Senior Vice President, Indegene.
- “I am thrilled to join Indegene and help life sciences companies evolve their go-to-market strategy and optimize impact through an omnichannel approach.”
Retrieved on:
Thursday, November 17, 2022
Environment,
Organization,
Information technology,
Fu Foundation School of Engineering and Applied Science,
Columbia University School of Nursing,
Physician,
RTÉ Executive Board,
Independent director,
Patient,
National Center for Nanoscience and Technology,
Adviser,
Health,
National Center for Women & Information Technology,
Applied science,
Woman,
Johnson & Johnson,
Management,
Pharmaceutical industry,
Indegene,
Engineering PRINCETON, N.J. and BANGALORE, India, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Georgia Papathomas as a Non-Executive Independent Director to the Board.
Key Points:
- PRINCETON, N.J. and BANGALORE, India, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the appointment of Georgia Papathomas as a Non-Executive Independent Director to the Board.
- Georgia brings several years of experience in life sciences.
- Life sciences companies are increasingly looking to personalize the patient and physician experience through omnichannel journeys.
- The company is propelled by an experienced leadership team, with a deep understanding of the sector and a focus on execution at scale, said Georgia Papathomas, Independent Director, Indegene.
Retrieved on:
Wednesday, November 2, 2022
PRINCETON, N.J. and BENGALURU, India, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced that it is helping AstraZeneca, a global biopharmaceutical company scale up its omnichannel operations across the globe with an aim to create a more personalized customer experience.
Key Points:
- PRINCETON, N.J. and BENGALURU, India, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced that it is helping AstraZeneca, a global biopharmaceutical company scale up its omnichannel operations across the globe with an aim to create a more personalized customer experience.
- Its partnerships with marketing platform providers will support the clients omnichannel operations efficiently, and at scale.
- Sanjay Parikh, Executive Director and EVP, Indegene, said, As patients and physicians progressively engage with life sciences companies through a wide variety of communication channels, omnichannel operations are vital to create personalized experiences at scale.
- We are excited at the opportunity to apply our healthcare domain expertise and technology accelerators to enable and empower life sciences companies on their omnichannel journey.
Retrieved on:
Wednesday, October 19, 2022
Physician,
Health,
Medicine,
Culture,
MOA,
Efficiency,
CRM,
DTC,
Patient,
Medication,
NEW,
Mechanism of action,
Drug discovery,
Acquisition,
Marketing,
TV,
CEO,
Social media,
Diabetes,
Seyfarth Shaw,
GLOBE,
LLP,
Solution,
HCPS,
Pharmaceutical industry,
Management,
Medical device,
Indegene CultHealth is a U.S.-based, full-service, healthcare marketing agency with significant experience in medical strategy, creative and omnichannel planning services.
Key Points:
- CultHealth is a U.S.-based, full-service, healthcare marketing agency with significant experience in medical strategy, creative and omnichannel planning services.
- With CultHealth, our life sciences clients benefit from partnering with a single service provider, all the way from brand strategy through commercialization.
- We believe that together we can build outstanding brand experiences, improve the effectiveness and efficiency of life sciences commercialization, and enable future ready healthcare.
- To learn more, please visit www.indegene.com
CultHealth is a full-service advertising and marketing agency focused on the unique needs of healthcare marketers.
Retrieved on:
Thursday, September 29, 2022
VP,
Machine learning,
CDP,
Organization,
Data management,
Partnership,
Industry,
CX,
Automation,
Solution,
HCP,
API,
Ecosystem,
Global Partnership on Artificial Intelligence,
HCPS,
GLOBE,
Communication,
SVP,
IOT,
Fine chemical,
Tealium,
Indegene Indegene will help global life sciences organizations of all sizes modernize their customer data priorities with Tealium.
Key Points:
- Indegene will help global life sciences organizations of all sizes modernize their customer data priorities with Tealium.
- The joint capabilities are built to resolve customer data collection and storage, marketing automation and implementation, and data and analytics - ensuring life sciences brands can leverage the full power of customer data intelligence based on HCP, patient, and caregiver data.
- As a leading global digital-first, life sciences commercialization partner, we are excited to collaborate with Tealium and help life sciences brands with embedded and AI-driven data capabilities that boost their omnichannel CX priorities.
- More than 850 leading businesses throughout the world trust Tealium to power their customer data strategies.
Retrieved on:
Tuesday, September 13, 2022
GM,
Corporation,
Organization,
LinkedIn,
Industry,
Environment,
Patient,
Pharmacovigilance,
Global regionalization,
Technology,
Ontario Basic Income Pilot Project,
Boehringer Ingelheim,
GLOBE,
Marketing,
EVP,
SVP,
Management,
Fine chemical,
Indegene The virtual event brings a stellar lineup of speakers sharing insights and experiences on the theme: Scaling transformation.
Key Points:
- The virtual event brings a stellar lineup of speakers sharing insights and experiences on the theme: Scaling transformation.
- The summit will unearth practical ideas life sciences leaders can implement and operate better in todays complex environment.
- The Indegene Digital Summit continues to be a leading, global platform for life sciences leaders to exchange ideas and learnings on the future of healthcare, said Gaurav Kapoor, Cofounder and EVP, Indegene.
- Indegene Digital Summit is a no-vendor, no-booth, global, knowledge exchange event for life sciences professionals.
Metaverse,
Patient,
Immersion,
GLOBE,
Physician,
Industry,
Binary relation,
Ali Baba,
Meta,
XRA,
CTO,
Microsoft,
Adoption,
Leadership,
Epic Games,
Internet,
Khronos Group,
Technology,
Adobe,
Health insurance,
Healthcare,
Indegene,
Nvidia BANGALORE, India and PRINCETON, N.J., July 20, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led healthcare solutions provider, today announced that it joined The Metaverse Standards Forum to foster interoperability within healthcare-contextualized open metaverse standards.
Key Points:
- BANGALORE, India and PRINCETON, N.J., July 20, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led healthcare solutions provider, today announced that it joined The Metaverse Standards Forum to foster interoperability within healthcare-contextualized open metaverse standards.
- The Metaverse Standards Forum brings together leading standards organizations and companies for industry-wide cooperation on interoperability standards needed to build the open metaverse.
- Open standards enable consistency across multiple metaverse implementations and can make the technology pervasive across a wide array of demographics.
- Indegene will contribute its knowledge of the healthcare industrys information standards and their portability for consideration in the overall metaverse standards being worked on by The Metaverse Standards Forum and its members.
